iNOVA4Health Seminar: Development of Biological Therapeutics for Health and Financial Value Creation - The Pharma Perspective
20 Mar 18
David Naveh, Ph.D., MBACEO Hemogem, ex- VP and ex-CTO of Bayer Biological Products Worldwide
20 Mar 18
David Naveh, Ph.D., MBACEO Hemogem, ex- VP and ex-CTO of Bayer Biological Products Worldwide
12 Mar 18
Monique M. van OersLaboratory of Virology, Wagninngen University, the Netherlands